JP2017509701A5 - - Google Patents

Download PDF

Info

Publication number
JP2017509701A5
JP2017509701A5 JP2017501126A JP2017501126A JP2017509701A5 JP 2017509701 A5 JP2017509701 A5 JP 2017509701A5 JP 2017501126 A JP2017501126 A JP 2017501126A JP 2017501126 A JP2017501126 A JP 2017501126A JP 2017509701 A5 JP2017509701 A5 JP 2017509701A5
Authority
JP
Japan
Prior art keywords
medicament according
medicament
cyclopropyl
carboxy
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017501126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017509701A (ja
JP6633609B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/021677 external-priority patent/WO2015143276A1/en
Publication of JP2017509701A publication Critical patent/JP2017509701A/ja
Publication of JP2017509701A5 publication Critical patent/JP2017509701A5/ja
Application granted granted Critical
Publication of JP6633609B2 publication Critical patent/JP6633609B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017501126A 2014-03-20 2015-03-20 肝疾患および他の医学的障害の処置のためのカルボキシ−シクロプロピルウンデカノール化合物 Expired - Fee Related JP6633609B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461968082P 2014-03-20 2014-03-20
US61/968,082 2014-03-20
PCT/US2015/021677 WO2015143276A1 (en) 2014-03-20 2015-03-20 Carboxy-cyclopropyl undecanol compounds for treatment of liver disease and other medical disorders

Publications (3)

Publication Number Publication Date
JP2017509701A JP2017509701A (ja) 2017-04-06
JP2017509701A5 true JP2017509701A5 (OSRAM) 2018-04-26
JP6633609B2 JP6633609B2 (ja) 2020-01-22

Family

ID=54145365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017501126A Expired - Fee Related JP6633609B2 (ja) 2014-03-20 2015-03-20 肝疾患および他の医学的障害の処置のためのカルボキシ−シクロプロピルウンデカノール化合物

Country Status (6)

Country Link
US (1) US20170209402A1 (OSRAM)
EP (1) EP3119388B1 (OSRAM)
JP (1) JP6633609B2 (OSRAM)
AU (1) AU2015231076B2 (OSRAM)
CA (1) CA2942100A1 (OSRAM)
WO (1) WO2015143276A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018536710A (ja) * 2015-11-06 2018-12-13 ジェンファイア・セラピューティクス・インコーポレイテッドＧｅｍｐｈｉｒｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 混合型脂質異常症の治療
WO2019179494A1 (zh) * 2018-03-23 2019-09-26 深圳市塔吉瑞生物医药有限公司 取代的十五烷二酸化合物及药物组合物及其用途
CN112675159A (zh) * 2021-01-12 2021-04-20 杭州师范大学 L-苹果酸在制备防治肝脏缺血再灌注损伤药物中的应用
WO2024212248A1 (en) * 2023-04-14 2024-10-17 Meta Pharmaceuticals (Hk) Limited Substituted alkanoic-diacids compound and composition and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067489A2 (en) * 2003-01-23 2004-08-12 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
BR112013008675A2 (pt) * 2010-09-20 2016-06-21 Kareus Therapeutics Sa métodos e composições para o tratamento de diabetes e dislipidemia

Similar Documents

Publication Publication Date Title
JP2017509701A5 (OSRAM)
JP2017513836A5 (OSRAM)
WO2017044507A3 (en) Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
WO2016004093A3 (en) Therapeutic compositions including galectin-3 inhibitors and uses thereof
WO2011005646A3 (en) Pharmaceutical composition for a hepatitis c viral protease inhibitor
WO2012033792A3 (en) Treatment of diseases
WO2015183963A3 (en) Therapeutic compositions including redox-active parabenzoquinones and uses thereof
JP2011201907A5 (OSRAM)
JP2016511753A5 (OSRAM)
JP2018507914A5 (OSRAM)
JP2015517489A5 (OSRAM)
HK1198869A1 (en) Combination treatments for hepatitis c
WO2017083304A8 (en) Therapeutic compositions for treatment of human immunodeficiency virus
JP2016510326A5 (OSRAM)
JP2018529666A5 (OSRAM)
WO2015183995A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
JP2017537912A5 (OSRAM)
JP2017105862A5 (OSRAM)
CN109689652A (zh) 稠杂环类衍生物、其制备方法及其在医学上的应用
WO2015160907A3 (en) Potent and selective inhibitors of hepatitis c virus
HK1255481A1 (zh) 用於治疗hcv的方法
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
JP2018505218A5 (OSRAM)
JP2016537431A5 (OSRAM)
JP2016069317A5 (ja) 腎不全進行抑制剤、腎不全予防剤、尿毒症治療剤、インドキシル硫酸産生阻害剤、心血管系疾患予防剤、及び食品組成物